Indefinite Delivery Contract 75N95024D00023
Award Date
8/12/24
Last Date to Order
8/11/30
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Charles River Laboratories, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $48.6 million multiple-award indefinite delivery contract to conduct safety evaluation and toxicology studies in support of drug development. The contract has a 6-year ordering period and allows NCATS to issue task orders for in vitro and in vivo safety testing services, including genetic toxicology, general toxicology, and pharmacology...
This indefinite delivery contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Lovelace Biomedical Research Institute, a not-for-profit contract research organization. The $48.6 million multiple-award IDC has a 6-year ordering period from June 2024 to June 2030. The contract aims to procure safety evaluation and toxicology studies and related services to support drug development efforts at NCATS....
The federal contract IDV award is for safety evaluation and toxicology studies and related services to support drug development efforts of the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The prime contractor, SRI International, a nonprofit research and development institute, will provide in vitro and in vivo exploratory and Investigational New Drug (IND)-directed toxicology studies for small molecule and biologic...
This is a multiple award indefinite delivery contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to conduct safety evaluation and toxicology studies to support drug development. The $48.6 million contract has a 6-year ordering period from June 2024 to June 2030. The contractor, IIT Research Institute (IITRI), a non-profit research organization, will perform in vitro and in vivo exploratory and...
The National Institute of Environmental Health Sciences (NIEHS), a civilian federal agency, awarded an Indefinite Delivery Contract (IDC) to Charles River Laboratories, Inc. (doing business as Charles River) for $1,830,828.00 to provide laboratory animal diagnostic testing services in support of NIEHS requirements. The contract has an ultimate completion date of July 17, 2029. Under this IDC, NIEHS has issued two firm fixed-price delivery orders to Charles River. The first order, valued at...
The Department of the Navy Bureau of Medicine and Surgery awarded an Indefinite Delivery Contract (IDC) to Charles River Laboratories, Inc. (doing business as Charles River) to provide F344 RATS STRAIN. This single-award contract has a potential value of $1,134,220.00 and a period of performance from January 3, 2024 to January 2, 2029. Charles River Laboratories is a contract research company that provides products and services to support pharmaceutical and biotechnology research and...
This indefinite delivery contract was awarded by the Office of the Director, a civilian federal agency, to Charles River Laboratories, Inc., a for-profit global contract research organization. The contract, valued at up to $98.8 million, provides a multiple award vehicle for Charles River to deliver a range of essential products and services to support the agency's biomedical research and development efforts. This likely includes supplying laboratory animals, diagnostic testing, virus...
This indefinite delivery contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to the Lovelace Biomedical Research Institute. The contract has a ceiling value of $48,882,666.00 and a period of performance through August 5, 2030. The purpose of this IDC is to obtain pharmacology studies, animal model development, and related services to support NCATS' Division of Preclinical Innovation drug...
This indefinite delivery contract was awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian federal agency, to Charles River Laboratories, Inc. The $1.5 million single-award contract has a period of performance through June 2029 and aims to provide NIEHS with barrier-reared and maintained rats, mice, hamsters, gerbils, and guinea pigs, as well as specialized animal services. Charles River Laboratories is a global company that supplies essential products and...
The federal contract IDV award is for "PHARMACOLOGY STUDIES AND ANIMAL MODEL DEVELOPMENT AND RELATED SERVICES FOR DRUG DEVELOPMENT" and was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH). The multiple-award, indefinite delivery contract has a ceiling value of $48,882,666.00 and a period of performance through August 5, 2030. The prime contractor is Advanced Bioscience Laboratories, Inc....
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order 75N95024D00023-75N95024F00001 | Charles River Laboratories, Inc. | $1.0k | 8/12/24 | 9/30/24 | 8/12/24 |